Yes: "Of 44 subjects, 27 (61%) completed 2 years of clinical follow-up, 34 (77%) had 1 year of complete clinical follow-up, and 39 (89%) contributed to the analysis". The good news: "The proportion of subjects who discontinued study participation was similar in each treatment arm"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.